ArticleScientific reports2025
Effects of a multimodal physical therapy approach on breast cancer-related lymphedema: a retrospective pre-post study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of physical therapy for prevention and treatment of postoperative lymphedema in breast cancer: a systematic review and meta-analysis.Frontiers in oncology · 2026Pooled it
- Predictors of response to compression therapy in breast cancer-related lymphoedema: a systematic review and meta-analysis.EClinicalMedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the availability of numerous lymphedema treatments, integrating physical therapy for breast cancer-related lymphedema (BCRL) management has limited evidence. The objective is to evaluate the effect of a multimodal physical therapy approach in reducing upper limb (UL) lymphedema and improving shoulder range of motion (ROM) in women with BCRL. A retrospective study was conducted with 19 women diagnosed with BCRL. UL circumference and shoulder ROM were assessed before and after four weeks of therapy and showed significant improvement (p < 0.05). The mean difference between baseline and 4-week intervention was 2.11 cm for UL circumference (95% CI: 1.54, 2.68; Cohen’s d = 1.35), 46.31o for shoulder flexion (95% CI -57.5, -35.1; Cohen’s d = 1.68), 10o for shoulder extension (95% CI -13.4, -6.59; Cohen’s d = 1.74), 47.36o for shoulder abduction (95% CI -60.35, -34.38; Cohen’s d = 1.67), 18.94o for shoulder internal rotation (95% CI -24.4, -13.4; Cohen’s d = 1.37) and 16.05o for shoulder external rotation (95% CI -20.03, -12.07; Cohen’s d = 1.51). Women with BCRL showed significant improvements in lymphedema and shoulder mobility following four weeks of therapy. Further, robust randomised clinical trials are required to substantiate these findings in Indian women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.